Chlamydia trachomatis Native Protein

Product Discontinued

Chlamydia trachomatis Native Protein Summary

• Description: Chlamydia trachomatis LGV type II strain 434.
  
  

  Source:Chlamydia trachomatis

• Preparation Method: Optimally infected cells are washed and disrupted into a small volume of phosphate buffered saline, subjected to 3 freeze/thaw cycles and centrifuged to remove cellular debris. The preparation is inactivated by heat treatment and 0.05% Triton X-100. Inact
• Protein/Peptide Type: Native Protein

Applications/Dilutions

• Dilutions:
  • ELISA

Packaging, Storage & Formulations

• Storage: Store at -80C. Avoid freeze-thaw cycles.
• Buffer: PBS, 0.05% Triton X-100
• Concentration: 4.2 mg/ml

Alternate Names for Chlamydia trachomatis Native Protein

• C.trachomatis

Background

Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%. Chlamydia is one of the leading causes of blindness in underdeveloped countries.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.